{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T08:15:48Z","timestamp":1777709748034,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-024-04184-0","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T09:03:54Z","timestamp":1708419834000},"page":"1929-1939","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Gold nanoshells for prostate cancer treatment: evidence for deposition in abdominal organs"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9497-5412","authenticated-orcid":false,"given":"Sonia","family":"Gaur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7339-8107","authenticated-orcid":false,"given":"Erica B.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3545-7654","authenticated-orcid":false,"given":"Daniel K.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6591-3212","authenticated-orcid":false,"given":"Maria","family":"Masotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7943-7851","authenticated-orcid":false,"given":"Matthew S.","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvin K.","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8755-6583","authenticated-orcid":false,"given":"James H.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,20]]},"reference":[{"issue":"37","key":"4184_CR1","doi-asserted-by":"publisher","first-page":"18590","DOI":"10.1073\/pnas.1906929116","volume":"116","author":"AR Rastinehad","year":"2019","unstructured":"Rastinehad AR, Anastos H, Wajswol E, et al. Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study. Proc Natl Acad Sci U S A. Sep 10 2019;116(37):18590-18596. doi:https:\/\/doi.org\/10.1073\/pnas.1906929116","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"6","key":"4184_CR2","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1177\/1091581812465969","volume":"31","author":"SC Gad","year":"2012","unstructured":"Gad SC, Sharp KL, Montgomery C, Payne JD, Goodrich GP. Evaluation of the toxicity of intravenous delivery of auroshell particles (gold-silica nanoshells). Int J Toxicol. Nov-Dec 2012;31(6):584-94. doi:https:\/\/doi.org\/10.1177\/1091581812465969","journal-title":"Int J Toxicol. Nov-Dec"},{"issue":"1","key":"4184_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1148\/radiology.177.1.2399310","volume":"177","author":"JE Kuhlman","year":"1990","unstructured":"Kuhlman JE, Teigen C, Ren H, Hruban RH, Hutchins GM, Fishman EK. Amiodarone pulmonary toxicity: CT findings in symptomatic patients. Radiology. Oct 1990;177(1):121-5. doi:https:\/\/doi.org\/10.1148\/radiology.177.1.2399310","journal-title":"Radiology."},{"issue":"6","key":"4184_CR4","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s11604-022-01379-7","volume":"41","author":"F Bruno","year":"2023","unstructured":"Bruno F, Albano D, Agostini A, et al. Imaging of metabolic and overload disorders in tissues and organs. Jpn J Radiol. Jun 2023;41(6):571-595. doi:https:\/\/doi.org\/10.1007\/s11604-022-01379-7","journal-title":"Jpn J Radiol."},{"issue":"6","key":"4184_CR5","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1148\/rg.296095513","volume":"29","author":"DT Boll","year":"2009","unstructured":"Boll DT, Merkle EM. Diffuse liver disease: strategies for hepatic CT and MR imaging. Radiographics. Oct 2009;29(6):1591-614. doi:https:\/\/doi.org\/10.1148\/rg.296095513","journal-title":"Radiographics."},{"issue":"3","key":"4184_CR6","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s00261-014-0080-6","volume":"39","author":"K Gaetke-Udager","year":"2014","unstructured":"Gaetke-Udager K, Wasnik AP, Kaza RK, et al. Multimodality imaging of splenic lesions and the role of non-vascular, image-guided intervention. Abdom Imaging. Jun 2014;39(3):570-87. doi:https:\/\/doi.org\/10.1007\/s00261-014-0080-6","journal-title":"Abdom Imaging."},{"issue":"5\u20136","key":"4184_CR7","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s00508-018-1319-y","volume":"130","author":"P Pecnik","year":"2018","unstructured":"Pecnik P, Ranftl V, Windpessl M. High liver density on CT imaging due to amiodarone toxicity. Wien Klin Wochenschr. Mar 2018;130(5-6):220-221. doi:https:\/\/doi.org\/10.1007\/s00508-018-1319-y","journal-title":"Wien Klin Wochenschr."},{"issue":"4","key":"4184_CR8","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1001\/jama.2014.17942","volume":"313","author":"MM Siddiqui","year":"2015","unstructured":"Siddiqui MM, Rais-Bahrami S, Turkbey B, et al. Comparison of MR\/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA. Jan 27 2015;313(4):390-7. doi:https:\/\/doi.org\/10.1001\/jama.2014.17942","journal-title":"JAMA."},{"key":"4184_CR9","doi-asserted-by":"publisher","unstructured":"Sekhoacha M, Riet K, Motloung P, Gumenku L, Adegoke A, Mashele S. Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches. Molecules. Sep 5 2022;27(17)doi:https:\/\/doi.org\/10.3390\/molecules27175730","DOI":"10.3390\/molecules27175730"},{"issue":"12","key":"4184_CR10","doi-asserted-by":"publisher","first-page":"T297","DOI":"10.1530\/ERC-17-0145","volume":"24","author":"M Gamat","year":"2017","unstructured":"Gamat M, McNeel DG. Androgen deprivation and immunotherapy for the treatment of prostate cancer. Endocr Relat Cancer. Dec 2017;24(12):T297-T310. doi:https:\/\/doi.org\/10.1530\/ERC-17-0145","journal-title":"Endocr Relat Cancer."},{"issue":"4","key":"4184_CR11","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.eururo.2013.05.048","volume":"66","author":"M Valerio","year":"2014","unstructured":"Valerio M, Ahmed HU, Emberton M, et al. The role of focal therapy in the management of localised prostate cancer: a systematic review. Eur Urol. Oct 2014;66(4):732-51. doi:https:\/\/doi.org\/10.1016\/j.eururo.2013.05.048","journal-title":"Eur Urol."},{"issue":"2","key":"4184_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.prnil.2015.03.007","volume":"3","author":"S Marshall","year":"2015","unstructured":"Marshall S, Taneja S. Focal therapy for prostate cancer: The current status. Prostate Int. Jun 2015;3(2):35-41. doi:https:\/\/doi.org\/10.1016\/j.prnil.2015.03.007","journal-title":"Prostate Int."},{"issue":"1","key":"4184_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.eururo.2021.08.005","volume":"81","author":"JS Hopstaken","year":"2022","unstructured":"Hopstaken JS, Bomers JGR, Sedelaar MJP, Valerio M, Futterer JJ, Rovers MM. An Updated Systematic Review on Focal Therapy in Localized Prostate Cancer: What Has Changed over the Past 5 Years? Eur Urol. Jan 2022;81(1):5-33. doi:https:\/\/doi.org\/10.1016\/j.eururo.2021.08.005","journal-title":"Eur Urol."},{"issue":"1","key":"4184_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.eururo.2021.10.005","volume":"81","author":"AL Abreu","year":"2022","unstructured":"Abreu AL, Kaneko M, Cacciamani GE, Lebastchi AH. Focal Therapy for Prostate Cancer: Getting Ready for Prime Time. Eur Urol. Jan 2022;81(1):34-36. doi:https:\/\/doi.org\/10.1016\/j.eururo.2021.10.005","journal-title":"Eur Urol."},{"issue":"8","key":"4184_CR15","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.clon.2013.05.002","volume":"25","author":"V Kasivisvanathan","year":"2013","unstructured":"Kasivisvanathan V, Emberton M, Ahmed HU. Focal therapy for prostate cancer: rationale and treatment opportunities. Clin Oncol (R Coll Radiol). Aug 2013;25(8):461-73. doi:https:\/\/doi.org\/10.1016\/j.clon.2013.05.002","journal-title":"Clin Oncol (R Coll Radiol)."},{"issue":"22","key":"4184_CR16","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1002\/asia.201800149","volume":"13","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Dai Z. New Strategies in the Design of Nanomedicines to Oppose Uptake by the Mononuclear Phagocyte System and Enhance Cancer Therapeutic Efficacy. Chem Asian J. Nov 16 2018;13(22):3333-3340. doi:https:\/\/doi.org\/10.1002\/asia.201800149","journal-title":"Chem Asian J."},{"issue":"11","key":"4184_CR17","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/j.addr.2004.02.014","volume":"56","author":"L Brannon-Peppas","year":"2004","unstructured":"Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev. Sep 22 2004;56(11):1649-59. doi:https:\/\/doi.org\/10.1016\/j.addr.2004.02.014","journal-title":"Adv Drug Deliv Rev."},{"issue":"4","key":"4184_CR18","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2217\/nnm.10.23","volume":"5","author":"S Nie","year":"2010","unstructured":"Nie S. Understanding and overcoming major barriers in cancer nanomedicine. Nanomedicine (Lond). Jun 2010;5(4):523-8. doi:https:\/\/doi.org\/10.2217\/nnm.10.23","journal-title":"Nanomedicine (Lond)."},{"issue":"1","key":"4184_CR19","first-page":"1","volume":"2016","author":"STA Wilhelm","year":"2016","unstructured":"Wilhelm S TA, Dai Q, Ohta S, Audet J, Dvorak HF, Chan WCW. Analysis of nanoparticle delivery to tumours. Nature Reviews Perspectives. May 2016 2016;1:1-12.","journal-title":"Nature Reviews Perspectives."},{"issue":"8","key":"4184_CR20","doi-asserted-by":"publisher","first-page":"8423","DOI":"10.1021\/acsnano.8b03900","volume":"12","author":"Q Dai","year":"2018","unstructured":"Dai Q, Wilhelm S, Ding D, et al. Quantifying the Ligand-Coated Nanoparticle Delivery to Cancer Cells in Solid Tumors. ACS Nano. Aug 28 2018;12(8):8423-8435. doi:https:\/\/doi.org\/10.1021\/acsnano.8b03900","journal-title":"ACS Nano."},{"issue":"7","key":"4184_CR21","doi-asserted-by":"publisher","first-page":"777","DOI":"10.4155\/tde.15.33","volume":"6","author":"IB Magana","year":"2015","unstructured":"Magana IB, Yendluri RB, Adhikari P, et al. Suppression of the reticuloendothelial system using lambda-carrageenan to prolong the circulation of gold nanoparticles. Ther Deliv. Jul 2015;6(7):777-83. doi:https:\/\/doi.org\/10.4155\/tde.15.33","journal-title":"Ther Deliv."},{"key":"4184_CR22","doi-asserted-by":"publisher","unstructured":"Krissak R, Elgert M, Kusch Br, H\u00a81nerbein R. Gold as a Potential Contrast Agent for Dual-Energy CT. Advances in Molecular Imaging. 2013;Vol.03No.04:6. 37798. doi:https:\/\/doi.org\/10.4236\/ami.2013.34006","DOI":"10.4236\/ami.2013.34006"},{"key":"4184_CR23","doi-asserted-by":"publisher","unstructured":"Bernstein AL, Dhanantwari A, Jurcova M, et al. Improved sensitivity of computed tomography towards iodine and gold nanoparticle contrast agents via iterative reconstruction methods. Sci Rep. May 17 2016;6:26177. doi:https:\/\/doi.org\/10.1038\/srep26177","DOI":"10.1038\/srep26177"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-024-04184-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-024-04184-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-024-04184-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T12:05:03Z","timestamp":1719576303000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-024-04184-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,20]]},"references-count":23,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["4184"],"URL":"https:\/\/doi.org\/10.1007\/s00261-024-04184-0","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,20]]},"assertion":[{"value":"7 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Sonia Gaur reports royalties from the National Institutes of Health for licensed intellectual property. Matthew S. Davenport reports royalties from Wolters Kluwer and uptodate.com. Arvin K. George reports relationships with BK Medical, Francis Medical, Hifu Prostate Services, Lina Medical, Nanospectra Biosciences, Philips Medical, and Sonablate Corporation. The other authors report that they have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This retrospective study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Medical School Institutional Review Board (IRBMED) of the University of Michigan approved this study (12 July 2022; HUM00219693), with waiver of informed consent. The study was performed in a HIPAA-compliant manner.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and informed consent"}}]}}